Drugs / TISSEEL Lyo
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04083807 | Jul → Oct 2019 | — | Baxter Healthcare Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TISSEEL Lyo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04083807 ↗ |
| Modality | Protein / enzyme biologic | “Fibrin sealant Vapor Heated, Solvent/Detergent-Treated, with 500 IU/mL Thrombin” NCT04083807 ↗ |